Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttlingM. Phillip DeYoung, Leif W. Ellisen|Genes & Development|2008Cited by 696
An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancerDaniel Morgensztern, Pilar Garrido, Enriqueta Felip et al.|Lung Cancer|2019Cited by 24